The Export Trend of Chinese Pharmaceutical Packaging Industry under the post-COVID19 situation

From the perspective of the international market, the world has entered the post-epidemic era since March. There are many rhetoric about China's manufacturing, China's export, and China's supply chain. Today, we will talk about the export trend of the pharmaceutical packaging industry after the epidemic from the perspective of a producer and an exporter.

Volatility in international markets
2022 is already halfway through, and the international situation has changed a lot. We cannot analyze it from a macro-political perspective, but the aftermath of the changes in the international situation has indeed made us producers feel the impact of changes in the general environment.
Russian-Ukrainian War
The Russian-Ukrainian war has come to an end, but economic changes are just beginning to reverberate. In the early stage of the war between Ukraine and Russia, the bank of the former was unable to pay for the goods, and the whole line was paralyzed, but the latter was still in the early stage of the war and had not been affected (the latter economic sanctions are another matter). By the middle of the war, freight transport was severely affected, and rail transport in Europe and Asia was hindered. It is now late in the war, and a large number of Russian customers are looking for new suppliers in other Asian countries. The shocking cost of European shipping, the limited payment, and the no longer cooperating with European countries have started a new reshuffle of supply and sales in Asia.
Made in Vietnam
This is also a hot word in international trade this year, called MADE IN VIETNAM - Made in Vietnam. As an emerging manufacturing and exporting country emerging after the epidemic, Vietnam received orders from the electronics industry in the third quarter. Anyone can find it anywhere online. However, the surge in demand will inevitably usher in a rise in prices, which is an external adjustment of the economy. In the past few days, our Vietnamese customers said that the local raw material prices have risen too much. This can't help but remind me of the rise in raw materials in China at the end of 2021, which is also the cause of the epidemic. At that time, the epidemic in China was well controlled. In the context of the global manufacturing downturn, it supported half of the sky, and the result was still that raw material prices skyrocketed. This also confirms that the economy is a cycle of reincarnation.

Status of domestic producers
Let's talk about ourselves, Made in China, MADE IN CHINA. Talking about our pharmaceutical packaging industry, using one word to describe it is enterprise stratification. Some companies have received soft orders and have already completed 200% of their orders, while others have lost 90% of their orders and stopped production. Many people think that our pharmaceutical packaging materials are related to the pharmaceutical industry, and they will definitely not worry about business during the epidemic. But the status quo is cruel. In fact, this is the situation in many industries. But this is not brought about by the epidemic. The epidemic is just a catalyst, which accelerates the prosperity of enterprises and accelerates the decline of enterprises.

What to do to break through?
How can we avoid becoming the company that loses 90% of orders and join the queue of companies that take orders and get soft?
1. Exposure. To know that the epidemic has brought about a reshuffle of suppliers, it must appear when customers search for suppliers again.
2. Repeat. Repeat the exposure multiple times to deepen the impression.
3. Internal strength is solid. Manufacturing enterprises, products are the foundation.
4. Persevere. When the general environment is down, the more you have to persevere. The economy is a cycle, and after a downturn there must be a new upswing, so you have to hold on to the next upswing.

Interpret the new industry trends and give you a different idea of ​​pharmaceutical packaging materials!